FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 100 mg/10 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 30 g/3000 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 30 g/3000 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 30 g/3000 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 100 mg/10 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 100 mg/10 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 100 mg/10 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 30 g/3000 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 100 mg/10 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1 g/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.25 g/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.75 g/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 300 g/3000 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 2 g/500 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/500 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.75 g/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 2 g/500 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1 g/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 2 g/500 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.75 g/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.75 g/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/500 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/250 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 2 g/500 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1 g/250 mL | 2022-1 | source_no_ndc | 2026-11-12 |